113 related articles for article (PubMed ID: 23321267)
1. Distinct composition of human fetal HDL attenuates its anti-oxidative capacity.
Sreckovic I; Birner-Gruenberger R; Obrist B; Stojakovic T; Scharnagl H; Holzer M; Scholler M; Philipose S; Marsche G; Lang U; Desoye G; Wadsack C
Biochim Biophys Acta; 2013 Apr; 1831(4):737-46. PubMed ID: 23321267
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
[TBL] [Abstract][Full Text] [Related]
3. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
4. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
5. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
Lee JH; Park JH; Lee SH; Kim JR; Cho KH
Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
[TBL] [Abstract][Full Text] [Related]
6. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
Park KH; Shin DG; Kim JR; Hong JH; Cho KH
Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
[TBL] [Abstract][Full Text] [Related]
7. Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells.
Augsten M; Hackl H; Ebner B; Chemelli A; Glatter O; Marsche G; Lang U; Desoye G; Wadsack C
Physiol Genomics; 2011 Nov; 43(22):1255-62. PubMed ID: 21954452
[TBL] [Abstract][Full Text] [Related]
8. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
[TBL] [Abstract][Full Text] [Related]
9. [Abnormality of HDL subfractions in cholesteryl ester transfer protein deficiency].
Miida T; Inano K; Nakamura Y; Matsuto T; Hoshiyama M; Kaneko K; Okada M
Rinsho Byori; 1996 Sep; 44(9):865-70. PubMed ID: 8911072
[TBL] [Abstract][Full Text] [Related]
10. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
11. Effects of anaerobic training on paraoxonase-1 enzyme (PON1) activities of high density lipoprotein subgroups and its relationship with PON1-Q192R phenotype.
Turgay F; Şişman AR; Aksu AÇ
J Atheroscler Thromb; 2015; 22(3):313-26. PubMed ID: 25735253
[TBL] [Abstract][Full Text] [Related]
12. Gestational diabetes mellitus modulates neonatal high-density lipoprotein composition and its functional heterogeneity.
Sreckovic I; Birner-Gruenberger R; Besenboeck C; Miljkovic M; Stojakovic T; Scharnagl H; Marsche G; Lang U; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Desoye G; Wadsack C
Biochim Biophys Acta; 2014 Nov; 1841(11):1619-27. PubMed ID: 25130684
[TBL] [Abstract][Full Text] [Related]
13. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
14. Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease.
Stadler JT; Wadsack C; Marsche G
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808220
[TBL] [Abstract][Full Text] [Related]
15. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications.
Cho KH
BMB Rep; 2009 Jul; 42(7):393-400. PubMed ID: 19643035
[TBL] [Abstract][Full Text] [Related]
16. The role of paraoxonase 1 in regulating high-density lipoprotein functionality during aging.
Khalil A; Kamtchueng Simo O; Ikhlef S; Berrougui H
Can J Physiol Pharmacol; 2017 Oct; 95(10):1254-1262. PubMed ID: 28746818
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 and HDL maturation.
Gugliucci A; Menini T
Clin Chim Acta; 2015 Jan; 439():5-13. PubMed ID: 25261854
[TBL] [Abstract][Full Text] [Related]
18. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
Noto H; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
Biochem Biophys Res Commun; 2001 Nov; 289(2):395-401. PubMed ID: 11716486
[TBL] [Abstract][Full Text] [Related]
19. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function.
James RW; Deakin SP
Adv Exp Med Biol; 2010; 660():173-81. PubMed ID: 20221880
[TBL] [Abstract][Full Text] [Related]
20. Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects.
Strunz CC; Oliveira TV; Vinagre JC; Lima A; Cozzolino S; Maranhão RC
Nutr Res; 2008 Mar; 28(3):151-5. PubMed ID: 19083402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
